Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Horwitz DA, Fahmy TM, Piccirillo CA, La Cava A.

Trends Immunol. 2019 Oct;40(10):888-908. doi: 10.1016/j.it.2019.08.003. Epub 2019 Oct 7. Review.

PMID:
31601519
2.

Editorial: Innate Immunity Pathways in Autoimmune Diseases.

Zouali M, La Cava A.

Front Immunol. 2019 Jun 4;10:1245. doi: 10.3389/fimmu.2019.01245. eCollection 2019. No abstract available.

3.

The Influence of Diet and Obesity on Gene Expression in SLE.

La Cava A.

Genes (Basel). 2019 May 27;10(5). pii: E405. doi: 10.3390/genes10050405. Review.

4.

Full squat produces greater neuromuscular and functional adaptations and lower pain than partial squats after prolonged resistance training.

Pallarés JG, Cava AM, Courel-Ibáñez J, González-Badillo JJ, Morán-Navarro R.

Eur J Sport Sci. 2019 May 15:1-10. doi: 10.1080/17461391.2019.1612952. [Epub ahead of print]

PMID:
31092132
5.

Human T cell repertoire: what happens in thymus does not stay in thymus.

La Cava A.

J Clin Invest. 2019 May 13;129(6):2195-2197. doi: 10.1172/JCI128371. eCollection 2019 May 13.

6.

Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.

Horwitz DA, Bickerton S, Koss M, Fahmy TM, La Cava A.

Arthritis Rheumatol. 2019 Apr;71(4):632-640. doi: 10.1002/art.40773. Epub 2019 Mar 5.

PMID:
30407752
7.

Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.

Jin WN, Gonzales R, Feng Y, Wood K, Chai Z, Dong JF, La Cava A, Shi FD, Liu Q.

Stroke. 2018 Jun;49(6):1471-1478. doi: 10.1161/STROKEAHA.118.020203. Epub 2018 Apr 25.

8.

Tregs in SLE: an Update.

La Cava A.

Curr Rheumatol Rep. 2018 Feb 21;20(2):6. doi: 10.1007/s11926-018-0714-8. Review.

PMID:
29464438
9.

Metabolic pressure and the breach of immunological self-tolerance.

De Rosa V, La Cava A, Matarese G.

Nat Immunol. 2017 Oct 18;18(11):1190-1196. doi: 10.1038/ni.3851.

PMID:
29044230
10.

Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage.

Zhang J, Shi K, Li Z, Li M, Han Y, Wang L, Zhang Z, Yu C, Zhang F, Song L, Dong JF, La Cava A, Sheth KN, Shi FD.

FASEB J. 2018 Jan;32(1):220-229. doi: 10.1096/fj.201700324R. Epub 2017 Sep 6.

11.

IRF1 and BATF: key drivers of type 1 regulatory T-cell differentiation.

Giang S, La Cava A.

Cell Mol Immunol. 2017 Aug;14(8):652-654. doi: 10.1038/cmi.2017.38. Epub 2017 Jun 19. No abstract available.

12.

Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations.

Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, Zhang C, Gonzales RJ, Sheth KN, La Cava A, Shi FD.

Immunity. 2017 Mar 21;46(3):474-487. doi: 10.1016/j.immuni.2017.02.015. Epub 2017 Mar 14.

13.

Leptin in inflammation and autoimmunity.

La Cava A.

Cytokine. 2017 Oct;98:51-58. doi: 10.1016/j.cyto.2016.10.011. Review.

14.

Regulatory T Cells in SLE: Biology and Use in Treatment.

Giang S, La Cava A.

Curr Rheumatol Rep. 2016 Nov;18(11):67. Review.

PMID:
27704250
15.

Role of Metabolism in the Immunobiology of Regulatory T Cells.

Galgani M, De Rosa V, La Cava A, Matarese G.

J Immunol. 2016 Oct 1;197(7):2567-75. doi: 10.4049/jimmunol.1600242. Review.

16.

Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.

Lourenço EV, Liu A, Matarese G, La Cava A.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10637-42. doi: 10.1073/pnas.1607101113. Epub 2016 Sep 1.

17.

The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.

Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, Faicchia D, Marone G, Tramontano D, Corona M, Alviggi C, Porcellini A, La Cava A, Mauri P, Matarese G.

Immunity. 2016 Mar 15;44(3):712. doi: 10.1016/j.immuni.2016.02.022. Epub 2016 Mar 15. No abstract available.

18.

The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.

Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, Faicchia D, Marone G, Tramontano D, Corona M, Alviggi C, Porcellini A, La Cava A, Mauri P, Matarese G.

Immunity. 2016 Feb 16;44(2):406-21. doi: 10.1016/j.immuni.2016.01.028. Erratum in: Immunity. 2016 Mar 15;44(3):712. Immunity. 2016 Mar 15;44(3):712.

19.

Editorial: Survive to Fight: Effector Treg Cells in Systemic Lupus Erythematosus.

La Cava A.

Arthritis Rheumatol. 2016 Jun;68(6):1327-9. doi: 10.1002/art.39616. No abstract available.

20.

Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.

Liu Q, Sanai N, Jin WN, La Cava A, Van Kaer L, Shi FD.

Nat Neurosci. 2016 Feb;19(2):243-52. doi: 10.1038/nn.4211. Epub 2016 Jan 11.

21.

Adaptive immune regulation in autoimmune diabetes.

Ferretti C, La Cava A.

Autoimmun Rev. 2016 Mar;15(3):236-41. doi: 10.1016/j.autrev.2015.11.008. Epub 2015 Nov 26. Review.

PMID:
26631820
22.

Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.

De Rosa V, Galgani M, Porcellini A, Colamatteo A, Santopaolo M, Zuchegna C, Romano A, De Simone S, Procaccini C, La Rocca C, Carrieri PB, Maniscalco GT, Salvetti M, Buscarinu MC, Franzese A, Mozzillo E, La Cava A, Matarese G.

Nat Immunol. 2015 Nov;16(11):1174-84. doi: 10.1038/ni.3269. Epub 2015 Sep 28.

23.

Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC; Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, La Cava A.

Clin Immunol. 2015 Dec;161(2):157-62. doi: 10.1016/j.clim.2015.09.007. Epub 2015 Sep 16.

24.

Putting together the autoimmunity puzzle.

La Cava A.

J Clin Invest. 2015 Jun;125(6):2184-6. doi: 10.1172/JCI82041. Epub 2015 Jun 1.

25.

Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus.

Amarilyo G, Iikuni N, Liu A, Matarese G, La Cava A.

PLoS One. 2014 Nov 17;9(11):e112826. doi: 10.1371/journal.pone.0112826. eCollection 2014.

26.

IL-17 promotes murine lupus.

Amarilyo G, Lourenço EV, Shi FD, La Cava A.

J Immunol. 2014 Jul 15;193(2):540-3. doi: 10.4049/jimmunol.1400931. Epub 2014 Jun 11.

27.

Bacteriophage-insensitive mutants for high quality Crescenza manufacture.

Chirico D, Gorla A, Verga V, Pedersen PD, Polgatti E, Cava A, Dal Bello F.

Front Microbiol. 2014 May 6;5:201. doi: 10.3389/fmicb.2014.00201. eCollection 2014.

28.

Regulatory CD4+ T cells promote B cell anergy in murine lupus.

Liu Y, Liu A, Iikuni N, Xu H, Shi FD, La Cava A.

J Immunol. 2014 May 1;192(9):4069-73. doi: 10.4049/jimmunol.1302897. Epub 2014 Mar 26.

29.

Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.

Figueroa FE, Cuenca Moreno J, La Cava A.

Expert Opin Drug Discov. 2014 May;9(5):555-66. doi: 10.1517/17460441.2014.897692. Epub 2014 Mar 22. Review.

PMID:
24655067
30.

Ischemic neurons recruit natural killer cells that accelerate brain infarction.

Gan Y, Liu Q, Wu W, Yin JX, Bai XF, Shen R, Wang Y, Chen J, La Cava A, Poursine-Laurent J, Yokoyama W, Shi FD.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2704-9. doi: 10.1073/pnas.1315943111. Epub 2014 Feb 3.

31.

miR-126, a new modulator of innate immunity.

Ferretti C, La Cava A.

Cell Mol Immunol. 2014 May;11(3):215-7. doi: 10.1038/cmi.2014.5. Epub 2014 Feb 17. No abstract available.

32.

Regulatory T cell proliferative potential is impaired in human autoimmune disease.

Carbone F, De Rosa V, Carrieri PB, Montella S, Bruzzese D, Porcellini A, Procaccini C, La Cava A, Matarese G.

Nat Med. 2014 Jan;20(1):69-74. doi: 10.1038/nm.3411. Epub 2013 Dec 8. Erratum in: Nat Med. 2014 Feb;20(2):220.

PMID:
24317118
33.

Leptin promotes lupus T-cell autoimmunity.

Amarilyo G, Iikuni N, Shi FD, Liu A, Matarese G, La Cava A.

Clin Immunol. 2013 Dec;149(3):530-3. doi: 10.1016/j.clim.2013.09.002. Epub 2013 Sep 12.

PMID:
24263282
34.

Genetic deficiency of β2-containing nicotinic receptors attenuates brain injury in ischemic stroke.

Liu Q, Tang Z, Gan Y, Wu W, Kousari A, La Cava A, Shi FD.

Neuroscience. 2014 Jan 3;256:170-7. doi: 10.1016/j.neuroscience.2013.10.049. Epub 2013 Oct 30.

PMID:
24184117
35.

Epigenetic dysregulation in systemic lupus erythematosus.

Liu A, La Cava A.

Autoimmunity. 2014 Jun;47(4):215-9. doi: 10.3109/08916934.2013.844794. Epub 2013 Oct 16. Review.

PMID:
24128164
36.

Common variable immunodeficiency: two mutations are better than one.

La Cava A.

J Clin Invest. 2013 Oct;123(10):4142-3. doi: 10.1172/JCI72476. Epub 2013 Sep 24.

37.

The rapid assembly of an elliptical galaxy of 400 billion solar masses at a redshift of 2.3.

Fu H, Cooray A, Feruglio C, Ivison RJ, Riechers DA, Gurwell M, Bussmann RS, Harris AI, Altieri B, Aussel H, Baker AJ, Bock J, Boylan-Kolchin M, Bridge C, Calanog JA, Casey CM, Cava A, Chapman SC, Clements DL, Conley A, Cox P, Farrah D, Frayer D, Hopwood R, Jia J, Magdis G, Marsden G, Martínez-Navajas P, Negrello M, Neri R, Oliver SJ, Omont A, Page MJ, Pérez-Fournon I, Schulz B, Scott D, Smith A, Vaccari M, Valtchanov I, Vieira JD, Viero M, Wang L, Wardlow JL, Zemcov M.

Nature. 2013 Jun 20;498(7454):338-41. doi: 10.1038/nature12184. Epub 2013 May 22.

PMID:
23698363
38.
39.

Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.

Yu Y, Liu Y, Shi FD, Zou H, Matarese G, La Cava A.

J Immunol. 2013 Apr 1;190(7):3054-8. doi: 10.4049/jimmunol.1203275. Epub 2013 Feb 27.

40.

Meta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression.

Galgani M, Nugnes R, Bruzzese D, Perna F, De Rosa V, Procaccini C, Mozzillo E, Cilio CM, Elding Larsson H, Lernmark A, La Cava A, Franzese A, Matarese G.

Diabetes. 2013 Jul;62(7):2481-91. doi: 10.2337/db12-1273. Epub 2013 Feb 8.

41.

Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.

Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, Siani A, Chan D, Martinez-Maza O, Chattopadhyay M, La Cava A.

Am J Neurodegener Dis. 2012;1(3):305-15. Epub 2012 Nov 21.

42.

Targeting the BLyS-APRIL signaling pathway in SLE.

La Cava A.

Clin Immunol. 2013 Sep;148(3):322-7. doi: 10.1016/j.clim.2012.11.010. Epub 2012 Dec 6. Review.

PMID:
23269199
43.

Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients.

Wu Q, Yang Q, Sun H, Li M, Zhang Y, La Cava A.

Autoimmunity. 2013 Feb;46(1):40-3. doi: 10.3109/08916934.2012.730587. Epub 2012 Oct 30.

PMID:
23039206
44.

NK cells inhibit T-bet-deficient, autoreactive Th17 cells.

Wu W, Shi S, Ljunggren HG, Cava AL, Van Kaer L, Shi FD, Liu R.

Scand J Immunol. 2012 Dec;76(6):559-66. doi: 10.1111/j.1365-3083.2012.02773.x.

45.

Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.

Procaccini C, De Rosa V, Galgani M, Carbone F, Cassano S, Greco D, Qian K, Auvinen P, Calì G, Stallone G, Formisano L, La Cava A, Matarese G.

J Immunol. 2012 Sep 15;189(6):2941-53. doi: 10.4049/jimmunol.1200935. Epub 2012 Aug 17.

46.

Adiponectin: a relevant player in obesity-related colorectal cancer?

La Cava A.

Gut. 2013 Apr;62(4):483-4. doi: 10.1136/gutjnl-2012-303034. Epub 2012 Jul 31. No abstract available.

PMID:
22851665
47.

Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1.

Liu G, Fiala M, Mizwicki MT, Sayre J, Magpantay L, Siani A, Mahanian M, Chattopadhyay M, La Cava A, Wiedau-Pazos M.

Am J Neurodegener Dis. 2012;1(1):60-74.

48.

In vivo veritas, in vitro artificia.

Matarese G, La Cava A, Horvath TL.

Trends Mol Med. 2012 Aug;18(8):439-42. doi: 10.1016/j.molmed.2012.05.003. Epub 2012 Jun 7.

49.

miRNA in systemic lupus erythematosus.

Amarilyo G, La Cava A.

Clin Immunol. 2012 Jul;144(1):26-31. doi: 10.1016/j.clim.2012.04.005. Epub 2012 May 3. Review.

PMID:
22659032
50.

The suppression of star formation by powerful active galactic nuclei.

Page MJ, Symeonidis M, Vieira JD, Altieri B, Amblard A, Arumugam V, Aussel H, Babbedge T, Blain A, Bock J, Boselli A, Buat V, Castro-Rodríguez N, Cava A, Chanial P, Clements DL, Conley A, Conversi L, Cooray A, Dowell CD, Dubois EN, Dunlop JS, Dwek E, Dye S, Eales S, Elbaz D, Farrah D, Fox M, Franceschini A, Gear W, Glenn J, Griffin M, Halpern M, Hatziminaoglou E, Ibar E, Isaak K, Ivison RJ, Lagache G, Levenson L, Lu N, Madden S, Maffei B, Mainetti G, Marchetti L, Nguyen HT, O'Halloran B, Oliver SJ, Omont A, Panuzzo P, Papageorgiou A, Pearson CP, Pérez-Fournon I, Pohlen M, Rawlings JI, Rigopoulou D, Riguccini L, Rizzo D, Rodighiero G, Roseboom IG, Rowan-Robinson M, Sánchez Portal M, Schulz B, Scott D, Seymour N, Shupe DL, Smith AJ, Stevens JA, Trichas M, Tugwell KE, Vaccari M, Valtchanov I, Viero M, Vigroux L, Wang L, Ward R, Wright G, Xu CK, Zemcov M.

Nature. 2012 May 9;485(7397):213-6. doi: 10.1038/nature11096.

PMID:
22575961

Supplemental Content

Support Center